Publisher: Adis International
ISSN: 1173-5503
Source: PharmacoEconomics and Outcomes News, Vol.1, Iss.410, 2003-01, pp. : 3-4
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Omalizumab enhances efficacy of established asthma medications
Inpharma, Vol. 1, Iss. 1382, 2003-01 ,pp. :
Omalizumab attacks paediatric asthma
Inpharma, Vol. 1, Iss. 1659, 2008-01 ,pp. :
Safety of omalizumab in asthma
By Tan Ricardo A Corren Jonathan
Expert Opinion on Drug Safety, Vol. 10, Iss. 3, 2011-05 ,pp. :
NICE no longer recommends omalizumab for asthma . . .
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 667, 2012-01 ,pp. :
Omalizumab effective in allergic asthma and allergic rhinitis
Inpharma, Vol. 1, Iss. 1408, 2003-01 ,pp. :